Abstract: A dosage form is disclosed comprising a wall surrounding a compartment, which comprises a first composition comprising a carboxymethylcellulose and a second composition comprising a higher molecular weigh carboxymethylcellulose. The first composition comprises a dosage amount of drug that delivers from the dosage form at a controlled rate over time.
Type:
Grant
Filed:
April 22, 1991
Date of Patent:
May 4, 1993
Assignee:
ALZA Corporation
Inventors:
Jeri D. Wright, Brian L. Barclay, David R. Swanson
Abstract: A corrosion resistent density element for use in ruminal delivery devices which fragments upon contact with the blades in grinding machinery without damage to the blades. The density element has density of at least about 1.5 g/ml and a transverse rupture strength no greater than about 30,000 psi.
Abstract: A dosage form is disclosed comprising a first layer and a second layer. The first layer provides immediate therapy and comprises a drug stereoisomer and the second layer provides prolonged therapy and comprises a drug racemate.
Type:
Grant
Filed:
May 1, 1991
Date of Patent:
April 20, 1993
Assignee:
Alza Corporation
Inventors:
David E. Edgren, Gurdish K. Bhatti, Judy A. Magruder
Abstract: A dosage form comprising (1) an immediately available dose of a beneficial drug followed by a timed delayed dose of drug, or (2) a timed delayed dose of drug.
Type:
Grant
Filed:
January 11, 1991
Date of Patent:
April 6, 1993
Assignee:
ALZA Corporation
Inventors:
Atul D. Ayer, Felix Theeuwes, Patrick S. L. Wong
Abstract: An osmotic device is disclosed comprising an exterior coat comprising an estrogenic and a progestogenic steroid that are delivered immediately as a contraceptive pair for fertility regulation in a female, and a compartment comprising an estrogenic steroid that is delivered at a controlled rate over a prolonged period of time for fertility regulation in a female.
Type:
Grant
Filed:
December 9, 1991
Date of Patent:
April 6, 1993
Assignee:
Alza Corporation
Inventors:
Jeri D. Wright, Jerry D. Childers, Brian L. Barclay, Patrick S.-L. Wong, Linda E. Atkinson
Abstract: A dosage form is disclosed comprising means for lessening the tackiness and/or irritation of the components of the dosage form to mucosal tissue. The dosage form provides means for forming in the dosage form a floc comprising a drug, which floc, when delivered from the dosage form, lessens the tackiness and/or irritation of the mucosal tissue of a warm-blooded recipient.
Type:
Grant
Filed:
December 6, 1991
Date of Patent:
April 6, 1993
Assignee:
ALZA Corporation
Inventors:
Liang C. Dong, Michael H. Dealey, Terry L. Burkoth, Patrick S. L. Wong, Jerry D. Childers, Brian L. Barclay
Abstract: A dosage form is disclosed comprising an anti-Parkinson's disease drug for administering to a patient in need of anti-Parkinson's disease therapy.
Type:
Grant
Filed:
March 5, 1992
Date of Patent:
March 9, 1993
Assignee:
ALZA Corporation
Inventors:
David E. Edgren, Howard A. Carpenter, Gurdish K. Bhatti, Atul D. Ayer
Abstract: A dosage form is disclosed comprising an anti-Parkinson's disease drug for administering to a patient in need of anti-Parkinson's disease therapy.
Type:
Grant
Filed:
May 7, 1990
Date of Patent:
March 2, 1993
Assignee:
ALZA Corporation
Inventors:
David E. Edgren, Howard A. Carpenter, Gurdish K. Bhatti, Atul D. Ayer
Abstract: A dosage form is disclosed comprising means for delaying the delivery of drug from the dosage form following the administration of the dosage form to a patient in need of drug therapy.
Type:
Grant
Filed:
November 26, 1991
Date of Patent:
March 2, 1993
Assignee:
ALZA Corporation
Inventors:
Frank Jao, Patrick S. L. Wong, Hoa T. Huynh, Kathy McChesney, Pamela K. Wat
Abstract: A dosage form is disclosed comprising a member selected from the group consisting of nicardipine and its pharmaceutically acceptable salts for administering to a patient in need of cardio-vascular therapy.
Type:
Grant
Filed:
November 18, 1991
Date of Patent:
February 16, 1993
Assignee:
ALZA Corporation
Inventors:
Joseph C. Deters, David R. Swanson, Stephen C. DeRosa
Abstract: The invention pertains to a dosage form for orally administering a drug in eight hours or less to the stomach and small intestine for a therapeutic result.
Type:
Grant
Filed:
August 19, 1991
Date of Patent:
January 12, 1993
Assignee:
Alza Corporation
Inventors:
George V. Guittard, Howard A. Carpenter, Ernest S. Quan, Patrick S. Wong, Lawrence G. Hamel
Abstract: A drug delivery device is disclosed for delivering a drug to the intestine and the colon. The device comprises external means for delaying the delivery of drug in the stomach, and hydrophobic means for preventing the passage of fluid through the delay means.
Abstract: The invention pertains to a delivery system comprising a biocide, with the delivery system designed and shaped for passage through the exit port of a urine container into the container.
Type:
Grant
Filed:
January 18, 1991
Date of Patent:
January 5, 1993
Assignee:
Alza Corporation
Inventors:
Tyler Watanabe, Su I. Yum, Eun S. Lee, Ivan W. Chin
Abstract: A delivery system is disclosed for delivering a beneficial agent to an animal. The delivery system comprises a wall that surrounds a lumen, said wall comprising a composition that limits the passage of fluid into the system and a composition that permits the passage of fluid into the system. The lumen comprises a beneficial agent and an expandable member. The delivery system comprises an exit means for delivering the beneficial agent.
Type:
Grant
Filed:
April 20, 1990
Date of Patent:
December 29, 1992
Assignee:
ALZA Corporation
Inventors:
Judy A. Magruder, James B. Eckenhoff, Richard Cortese, Jeremy C. Wright, John R. Peery
Abstract: A dosage form is disclosed comprising means for delaying the delivery of drug from the dosage form following the administration of the dosage form to a patient in need of drug therapy.
Type:
Grant
Filed:
June 27, 1991
Date of Patent:
November 3, 1992
Assignee:
Alza Corporation
Inventors:
Frank Jao, Patrick S. Wong, Hoa T. Huynh, Kathy McChesney, Pamela K. Wat
Abstract: A dosage form is disclosed comprising a coat that surrounds a drug. The coat comprises a subcoat and an overcoat thermally annealed to provide a single unit coat around the drug.
Abstract: A dosage form is disclosed that comprises means inside the dosage form for providing a substantially drug-free interval before the dosage form delivers a drug from inside the dosage form. The dosage form in an embodiment comprises a drug on the exterior of the dosage form, which drug is available for immediate delivery.
Type:
Grant
Filed:
August 31, 1990
Date of Patent:
October 20, 1992
Assignee:
ALZA Corporation
Inventors:
Patrick S. Wong, Felix Theeuwes, Atul D. Ayer, Anthony L. Kuczynski
Abstract: A dosage form comprising (1) an immediately available dose of a beneficial drug followed by a timed delayed dose of drug, or (2) a timed delayed dose of drug.
Type:
Grant
Filed:
July 25, 1991
Date of Patent:
August 25, 1992
Assignee:
Alza Corporation
Inventors:
Atul D. Ayer, Felix Theeuwes, Patrick S. L. Wong